The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Triggering TLR signaling in vaccination
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,193
Self-citationInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
Pasare, C., & Medzhitov, R. (2003) · Science · doi:10.1126/science.1078231 · Cited by 1,997
Self-citationEfficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.1994.03510330076038 · Cited by 1,918
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,861
Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors
Brightbill, H. D., Libraty, D. H., Krutzik, S. R., Yang, R.-B., Belisle, J. T., Bleharski, J. R., Maitland, M., Norgard, M. V., Plevy, S. E., Smale, S. T., et al. (1999) · Science · doi:10.1126/science.285.5428.732 · Cited by 1,661
Toll-like receptors control activation of adaptive immune responses
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., & Medzhitov, R. (2001) · Nature Immunology · doi:10.1038/ni712 · Cited by 1,365
Self-citationEisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A., & Bottomly, K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021340 · Cited by 1,171
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
Cella, M., Engering, A., Pinet, V., Pieters, J., & Lanzavecchia, A. (1997) · Nature · doi:10.1038/42030 · Cited by 1,123
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Toll-like receptor 3 promotes cross-priming to virus-infected cells
Schulz, O., Diebold, S. S., Chen, M., Näslund, T. I., Nolte, M. A., Alexopoulou, L., Azuma, Y.-T., Flavell, R. A., Liljeström, P., & Reis e Sousa, C. (2005) · Nature · doi:10.1038/nature03326 · Cited by 921
Type 1/Type 2 Immunity in Infectious Diseases
Spellberg, B., & Edwards, J. E. (2001) · Clinical Infectious Diseases · doi:10.1086/317537 · Cited by 911
Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2
Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A. K., Farber, J. M., Segal, D. M., Oppenheim, J. J., et al. (2002) · Science · doi:10.1126/science.1075565 · Cited by 902
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804
Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Function
Peng, G., Guo, Z., Kiniwa, Y., Voo, K. S., Peng, W., Fu, T., Wang, D. Y., Li, Y., Wang, H. Y., & Wang, R.-F. (2005) · Science · doi:10.1126/science.1113401 · Cited by 746
Steere, A. C., Sikand, V. K., Meurice, F., Parenti, D. L., Fikrig, E., Schoen, R. T., Nowakowski, J., Schmid, C. H., Laukamp, S., Buscarino, C., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390401 · Cited by 746
Speiser, D. E., Líénard, D., Rufer, N., Rubio‐Godoy, V., Rimoldi, D., Lejeune, F. J., Krieg, A. Μ., Cerottini, J., & Romero, P. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523373 · Cited by 640
Takeuchi, O., Kaufmann, A., Grote, K., Kawai, T., Hoshino, K., Morr, M., Mühlradt, P. F., & Akira, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.2.554 · Cited by 569
Hemagglutinin Protein of Wild-Type Measles Virus Activates Toll-Like Receptor 2 Signaling
Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider-Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., ter Meulen, V., & Schneider-Schaulies, S. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8729-8736.2002 · Cited by 509
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial
Vermorken, J. B., Claessen, A. M., van Tinteren, H., Gall, H. E., Ezinga, R., Meijer, S., Scheper, R. J., Meijer, C. J., Bloemena, E., Ransom, J. H., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07186-4 · Cited by 504
Diehl, L., den Boer, A. T., Schoenberger, S. P., van der Voort, E. I. H., Schumacher, T. N. M., Melief, C. J. M., Offringa, R., & Toes, R. E. M. (1999) · Nature Medicine · doi:10.1038/10495 · Cited by 469
Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R., & Aguzzi, A. (2004) · Nature Medicine · doi:10.1038/nm987 · Cited by 449
Hoebe, K., Janssen, E. M., Kim, S. O., Alexopoulou, L., Flavell, R. A., Han, J., & Beutler, B. (2003) · Nature Immunology · doi:10.1038/ni1010 · Cited by 446
Alexopoulou, L., Thomas, V., Schnare, M., Lobet, Y., Anguita, J., Schoen, R. T., Medzhitov, R., Fikrig, E., & Flavell, R. A. (2002) · Nature Medicine · doi:10.1038/nm732 · Cited by 435
Self-citationYang, Y., Huang, C.-T., Huang, X., & Pardoll, D. M. (2004) · Nature Immunology · doi:10.1038/ni1059 · Cited by 425
CD27 and CD70 in T cell and B cell activation
Borst, J., Hendriks, J., & Xiao, Y. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.04.004 · Cited by 419
Means, T. K., Hayashi, F., Smith, K. D., Aderem, A., & Luster, A. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5165 · Cited by 410
Tsuji, S., Matsumoto, M., Takeuchi, O., Akira, S., Azuma, I., Hayashi, A., Toyoshima, K., & Seya, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6883-6890.2000 · Cited by 409
Bulut, Y., Faure, E., Thomas, L., Equils, O., & Arditi, M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.987 · Cited by 381
Microbial Lipopeptides Stimulate Dendritic Cell Maturation Via Toll-Like Receptor 2
Hertz, C. J., Kiertscher, S. M., Godowski, P. J., Bouis, D. A., Norgard, M. V., Roth, M. D., & Modlin, R. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2444 · Cited by 356
Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
Colditz, G. A. (1994) · JAMA · doi:10.1001/jama.271.9.698 · Cited by 355
The immunobiology of the TLR9 subfamily
Wagner, H. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.011 · Cited by 341
Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88
Fremond, C. M., Yeremeev, V., Nicolle, D. M., Jacobs, M., Quesniaux, V. F., & Ryffel, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421027 · Cited by 318
Use of CpG oligodeoxynucleotides as immune adjuvants
Klinman, D. M., Currie, D., Gursel, I., & Verthelyi, D. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00148.x · Cited by 306
Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T., DiDonato, J., Dziarski, R., Akira, S., Schoenberger, S. P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4102 · Cited by 302
Cutting Edge: Immune Stimulation by Neisserial Porins Is Toll-Like Receptor 2 and MyD88 Dependent
Massari, P., Henneke, P., Ho, Y., Latz, E., Golenbock, D. T., & Wetzler, L. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1533 · Cited by 292
CD40 Ligation Releases Immature Dendritic Cells from the Control of Regulatory CD4+CD25+ T Cells
Serra, P., Amrani, A., Yamanouchi, J., Han, B., Thiessen, S., Utsugi, T., Verdaguer, J., & Santamaria, P. (2003) · Immunity · doi:10.1016/s1074-7613(03)00327-3 · Cited by 291
Biragyn, A., Surenhu, M., Yang, D., Ruffini, P. A., Haines, B. A., Klyushnenkova, E., Oppenheim, J. J., & Kwak, L. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6644 · Cited by 286
Cho, H. J., Takabayashi, K., Cheng, P.-M., Nguyen, M.-D., Corr, M., Tuck, S., & Raz, E. (2000) · Nature Biotechnology · doi:10.1038/75365 · Cited by 258
Bacterial Flagellin Is an Effective Adjuvant for CD4+ T Cells In Vivo
McSorley, S. J., Ehst, B. D., Yu, Y., & Gewirtz, A. T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3914 · Cited by 256
Baldridge, J. R., McGowan, P., Evans, J. T., Cluff, C., Mossman, S., Johnson, D., & Persing, D. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.7.1129 · Cited by 256
Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M., & Sher, A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00278-9 · Cited by 252
Jackson, D. C., Lau, Y. F., Le, T., Suhrbier, A., Deliyannis, G., Cheers, C., Smith, C., Zeng, W., & Brown, L. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406740101 · Cited by 236
TLR3 in antiviral immunity: key player or bystander?
Schröder, M., & Bowie, A. G. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.07.002 · Cited by 226
Spies, B., Hochrein, H., Vabulas, M., Huster, K., Busch, D. H., Schmitz, F., Heit, A., & Wagner, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5908 · Cited by 199
Wille-Reece, U., Wu, C.-Y., Flynn, B. J., Kedl, R. M., & Seder, R. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7676 · Cited by 185
Vaccinology: past achievements, present roadblocks and future promises
ANDRE, F. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00702-8 · Cited by 173
Schröder, N. W. J., Heine, H., Alexander, C., Manukyan, M., Eckert, J., Hamann, L., Göbel, U. B., & Schumann, R. R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2683 · Cited by 155
CpG-DNA Aided Cross-Priming by Cross-Presenting B Cells
Heit, A., Huster, K. M., Schmitz, F., Schiemann, M., Busch, D. H., & Wagner, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1501 · Cited by 141
Inherited disorders of human Toll‐like receptor signaling: immunological implications
Ku, C., Yang, K., Bustamante, J. C., Puel, A., von Bernuth, H., Filipe‐Santos, O., Lawrence, T. C., Chang, H., Al‐Mousa, H., Pïcard, C., et al. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00235.x · Cited by 132
Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances
Randolph, G. J., Sánchez‐Schmitz, G., & Angeli, V. (2004) · Springer Seminars in Immunopathology · doi:10.1007/s00281-004-0168-0 · Cited by 127
Liu, H.-M., Newbrough, S. E., Bhatia, S. K., Dahle, C. E., Krieg, A. Μ., & Weiner, G. J. (1998) · Blood · doi:10.1182/blood.v92.10.3730 · Cited by 122
Shackleton, M. J., Davis, I. D., Hopkins, W., Jackson, H. M., Dimopoulos, N., Tai, T. Y., Chen, Q., Parente, P., Jefford, M., Masterman, K., et al. (2004) · PubMed · Cited by 122
The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview
Stockfleth, E., Trefzer, U., Garcia-Bartels, C., Wegner, T., Schmook, T., & Sterry, W. (2003) · British Journal of Dermatology · doi:10.1046/j.0366-077x.2003.05626.x · Cited by 119
Heckelsmiller, K., Beck, S., Rall, K., Sipos, B., Schlamp, A., Tuma, E., Rothenfußer, S., Endres, S., & Hartmann, G. (2002) · European Journal of Immunology · Cited by 117
Akazawa, T., Masuda, H., Saeki, Y., Matsumoto, M., Takeda, K., Tsujimura, K., Kuzushima, K., Takahashi, T., Azuma, I., Akira, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1518 · Cited by 106
Wilson, C. C., McKinney, D. M., Anders, M., MaWhinney, S., Forster, J. E., Crimi, C., Southwood, S., Sette, A., Chesnut, R. W., Newman, M. J., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5611 · Cited by 103
TLR9−/− and TLR9+/+ mice display similar immune responses to a DNA vaccine
Babiuk, S., Mookherjee, N., Pontarollo, R. A., Griebel, P., den Hurk, S. V. D. L., Hecker, R., & Babiuk, L. A. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01938.x · Cited by 99
Toll-Like Receptor 2 Ligands as Adjuvants for Human Th1 Responses
Sieling, P. A., Chung, W., Duong, B. T., Godowski, P. J., & Modlin, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.194 · Cited by 99
Zhu, X., Ramos, T., Gras‐Masse, H., Kaplan, B. E., & BenMohamed, L. (2004) · European Journal of Immunology · doi:10.1002/eji.200425166 · Cited by 93
Okada, N., Mori, N., Koretomo, R., Okada, Y., Nakayama, T., Yoshie, O., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Mayumi, T., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302358 · Cited by 90
TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines
Tudor, D., Dubuquoy, C., Gaboriau‐Routhiau, V., Lefèvre, F., Charley, B., & Riffault, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.09.001 · Cited by 88
Tritel, M., Stoddard, A. M., Flynn, B. J., Darrah, P. A., Wu, C. Y., Wille, U., Shah, J. A., Huang, Y., Xu, L., Betts, M. R., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2538 · Cited by 77
Schjetne, K. W., Thompson, K. M., Nilsen, N. J., Flo, T. H., Fleckenstein, B. T., Iversen, J., Espevik, T., & Bogen, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.32 · Cited by 76
Latz, E., Franko, J., Golenbock, D., & Schreiber, J. R. (2004) · Journal of Immunology · doi:10.4049/jimmunol.172.4.2431 · Cited by 75
Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model
Otero, M. A., Calarota, S. A., Felber, B. K., Laddy, D. J., Pavlakis, G. N., Boyer, J., & Weiner, D. B. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.037 · Cited by 66
Eo, S. K., Lee, S., Kumaraguru, U., & Rouse, B. T. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00241-9 · Cited by 63
Benhnia, M. R., Wroblewski, D., Akhtar, M. N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1539 · Cited by 58
Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice
Przetak, M. M., Chow, J. C., Cheng, H., Rose, J., Hawkins, L. D., & Ishizaka, S. T. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00737-5 · Cited by 51
Yoder, A., Wang, X., Ma, Y., Philipp, M. T., Heilbrun, M. E., Weis, J. H., Kirschning, C. J., Wooten, R. M., & Weis, J. J. (2003) · Infection and Immunity · doi:10.1128/iai.71.7.3894-3900.2003 · Cited by 33
Al‐Bader, T., Christodoulides, M., Heckels, J. E., Holloway, J. A., Semper, A. E., & Friedmann, P. S. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5590-5597.2003 · Cited by 28
Köchling, J., König-Merediz, S. A., Stripecke, R., Buchwald, D., Korte, A., Einsiedel, H. G., Sack, F., Henze, G., Seeger, K., Wittig, B., et al. (2003) · PubMed · Cited by 21
Yamaguchi, N., Hiraoka, S.-I., Mukai, T., Takeuchi, N., Zhou, X., Ono, S., Kogo, M., Dunussi‐Joannopoulos, K., Ling, V., Wolf, S. F., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1347 · Cited by 17
Cited by
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Lipid A Modification Systems in Gram-Negative Bacteria
Raetz, C. R. H., Reynolds, C. M., Trent, M. S., & Bishop, R. E. (2007) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.010307.145803 · Cited by 1,340
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Yoo, J.-W., Irvine, D. J., Discher, D. E., & Mitragotri, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3499 · Cited by 1,236
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005
Targeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
Metadata
- Authors
- van Duin, D., Medzhitov, R., & Shaw, A. C.
- Venue
- Trends in Immunology
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 27
- Issue
- 1
- Pages
- 49-55
- ISSN
- 1471-4906 (ISSN-L)
- OpenAlex
- W2022890571
- Cited by
- 364
- References
- 75
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.